|
OCX | Oncocyte Corp |
|
|
OCX | Oncocyte Corp |
| In Vitro & In Vivo Diagnostic Substances |
| Book value per $ invested | $ 0.54 |
| Leverage | 86.17% |
| Market Cap | $ 17.8m |
| PE | 0.00 |
| Dividend Yield | 0.00% |
| Profit | $ -42.7m |
| Margin | -3138.20% |
OncoCyte Corporation, a molecular diagnostics company, researches, develops, and markets proprietary laboratory-developed tests for the detection of cancer in the United States and internationally. The company is headquartered in Irvine, California.